Multiple sclerosis in its European matrix

Multiple Sclerosis

Volumn 8, Issue 3, 2002, Pages 181-191

  McDonald, Ian ^a  

^a ROYAL COLLEGE OF PHYSICIANS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; GLATIRAMER; PLANT EXTRACT; SODIUM CHLORIDE; STRYCHNINE;

CLINICAL FEATURE; CLINICAL TRIAL; CONFERENCE PAPER; DISEASE COURSE; DRUG EFFECT; EUROPE; GENETIC ANALYSIS; HISTORY OF MEDICINE; HUMAN; MEDICAL EDUCATION; MEDICAL PRACTICE; MEDICAL RESEARCH; MULTIPLE SCLEROSIS; MUSCLE WEAKNESS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCRIPTION; RELAPSE; SYSTEMIC SCLEROSIS; VISUAL IMPAIRMENT; ARTICLE; HISTORY; MALE; MEDICAL RECORD; PATHOPHYSIOLOGY; PUBLIC FIGURE; UNITED KINGDOM;

DISEASE PROGRESSION; EUROPE; FAMOUS PERSONS; GREAT BRITAIN; HISTORY OF MEDICINE, 18TH CENT.; HUMAN; MALE; MEDICAL RECORDS; MULTIPLE SCLEROSIS; HISTORY, 18TH CENTURY; HUMANS;

EID: 0035989131     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1191/1352458502ms821oa     Document Type: Conference Paper

References (49)

1. The dissemination of multiple sclerosis: A Viking saga? A historical essay
2. The 150-year anniversary of multiple sclerosis: Does its early history give an aetiological clue?
3. Genetic susceptibility to multiple sclerosis
4. Antiquities of the House of Brunswick
5. Histologie de la sclérose en plaques
6. A population-based study of multiple sclerosis in twins: Update
7. The British Isles survey of multiple sclerosis in twins
8. Multiple sclerosis in 54 twinships: Concordance rate is independent of zygosity
9. Distribution of multiple sclerosis
10. The age-range of risk of developing multiple sclerosis. Evidence from a migrant population in Australia
11. The increasing incidence and prevalence on MS in a Sardinian province
12. A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22
13. A full genome search in multiple sclerosis
14. A complete genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex
15. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
16. A frameshift mutation of NOD2 associated with susceptibility to Crohn's disease
17. The effects of experimental demyelination of conduction in peripheral nerve: A histological and electrophysiological study: II. Electrophysiological observations
18. The effects of experimental demyelination on conduction and the central nervous system
19. Delayed visual evoked response in optic neuritis
20. Visual evoked response in diagnosis of multiple sclerosis
21. Magnetic resonance imaging (MR) in multiple sclerosis (MS): Pathological co-relation studies in 8 cases
22. Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications
23. Major differences in the dynamics of primary and secondary progressive multiple sclerosis
24. Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis
25. STIR sequences in NMR imaging of the optic nerve
26. The pathophysiology of acute optic neuritis. An association of gadolinium leakage with clinical and electrophysiological deficits
27. The pathophysiology of multiple sclerosis: The mechanisms underlying the production of symptoms and the natural history of the disease
28. Electrically active axons degenerate when exposed to nitric oxide
29. Increase of sodium channels in demyelinated lesions of multiple sclerosis
30. Recovery from optic neuritis is associated with a change in the distribution of cerebral response to visual stimulation: A functional magnetic resonance imaging study
31. The motor cortex shows adaptive functional changes to brain injury from multiple sclerosis
32. Cerebral plasticity in multiple sclerosis
33. Histopathology and blood - cerebrospinal fluid barrier in multiple sclerosis
34. Axonal pathology in multiple sclerosis. A historical note
35. Axonal damage in acute multiple sclerosis lesions
36. Axonal transaction in the lesions of multiple sclerosis
37. Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression
38. Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss
39. Nitric oxide-mediated mitochondrial damage in the brain: Mechanisms and implications for neurodegenerative diseases
40. Activity-dependent excitability changes in normal and demyelinated rat spinal axons
41. 2+ exchange in spinal cord white matter injury at physiological temperature
42. Protection of axons from degeneration resulting from exposure to nitric oxide
43. Partial sodium channel blockage protects axons from degeneration caused by the combination of impulse activity and exposure to nitric oxide
44. A working protocol to be used as a guideline for trials in multiple sclerosis